检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王海龙[1] 周兴春 杨涛[1] 冯作鹏 高广寿[1] 梁辉[1] WANG Hailong;ZHOU Xingchun;YANG Tao;FENG Zuopeng;GAO Guangshou;LIANG Hui(Department of Cardio-thoracic Surgery,the 942nd Hospital of PLA Joint Logistic Support Force,Yinchuan 750001,Ningxia,China)
机构地区:[1]中国人民解放军联勤保障部队第九四二医院心胸外科,宁夏银川750001
出 处:《中国美容医学》2024年第2期42-44,共3页Chinese Journal of Aesthetic Medicine
摘 要:目的:探讨非溶脂单孔充气法腔镜皮下乳腺切除术治疗男性乳腺发育症的方法及可行性。方法:回顾性分析2018年1月-2021年4月笔者科室收治的21例(32侧)男性乳腺发育症患者临床资料。所有患者均行经腋窝非溶脂单孔充气法腔镜皮下乳腺切除术。结果:所有患者均顺利完成手术,术后发生皮下积液1例,腔镜操作孔皮缘坏死1例,少量胸壁皮下气肿1例,均未发生乳头乳晕坏死、皮瓣坏死、血肿等并发症。所有患者双侧胸壁基本对称,乳头外形正常,均未出现复发病例。所有患者对术后美学效果满意。结论:非溶脂单孔充气法腔镜皮下乳腺切除术治疗男性乳腺发育症疗效好,并发症少,且具有良好的美学效果。Objective To investigate the technique and feasibility of non-liposuction single-port endoscopic surgery in the treatment of gynecomastia.Methods The clinical data of 21 cases of gynecomastia(including 10 cases of unilateral breast development and 11 cases of bilateral breast development,a total of 32 cases)treated in the author's hospital from January 2018 to April 2021 were analyzed retrospectively.All of them underwent trans-axillary single-port endoscopic subcutaneous mastectomy without liposuction.Results All patients successfully completed the operation.Post operative complications included 1 case of subcutaneous hydrops,1 case of skin necrosis around the endoscopic operation hole and 1 case of subcutaneous emphysema of chest wall.No complications such as nipple areola necrosis,flap necrosis and hematomas occurred.The bilateral chest walls of all patients were basically symmetrical,the nipple shape was normal,and there was no recurrence.All patients were satisfied with the postoperative aesthetic results.Conclusion Non-liposuction single-port endoscopic subcutaneous mastectomy is safe and effective,and has a good cosmetic effect.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.222.184.40